Own research center
performs a full development cycle: from the molecule
before registration of the drug. Biotech development
drugs - the priority of the company.
Location: Special Economic Zone in St. Petersburg (Neudorf site)
Area: over 1,500 sq. m.
Full-cycle development of medicinal products in accordance with GLP, GCP, GMP
In the near future -
full line release
biosimilars of insulin
